Ostatní
Návod 
Intellia Therapeutics, Inc.
NTLA
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.1B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-60%
ROA
-48%
PE
-3
PS
22
Cena 1R
6-28
⌀ Cena
11.45
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda
Profil
Intellia Therapeutics, Inc., společnost zabývající se editací genomu, se zaměřuje na vývoj terapie. Programy in vivo společnosti zahrnují NTLA- 2001, která je ve fázi 1 klinické studie pro léčbu amyloidózy transthyretinu, a NTLA- 2002 pro léčbu dědičného angioedému, stejně jako další programy zaměřené na játra, zahrnující hemofilii A a hemofilii B, hyperoxalurii typu 1 a nedostatek antitrypsinu alfa- 1. Plynovod ex vivo obsahuje NTLA-5001 pro léčbu akutní myeloidní leukémie a proprietární programy zaměřené na vývoj inženýrských buněčných terapií pro léčbu různých onkologických a autoimunitních poruch. Kromě toho nabízí nástroje sestávající z clusterovaného, pravidelně propojeného systému krátkých palindromických opakování/CRISPR asociovaného 9 (CRISPR/Cas9). Společnost Intellia Therapeutics, Inc. má licenční smlouvy a smlouvy o spolupráci s Institutes for BioMedical Research, Inc. na výrobu hematopoetických kmenových buněk pro léčbu srpkovité anémie; Regeneron Pharmaceuticals, Inc. na vývoj potenciálních produktů pro léčbu hemofilie A a hemofilie B; Ospedale San Raffaele; a strategickou spolupráci se společností SparingVision SAS na vývoji nových genomických léků využívajících technologii CRISPR/Cas9 pro léčbu očních onemocnění. Společnost byla dříve známá jako AZRN, Inc. Intellia Therapeutics, Inc. byla založena v roce 2014 a sídlí v Cambridge v Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
403
Založení
2016-05-06
Podobné společnosti
$ 21.54
- $ 0.05
$ 8.11
- $ 0.16
$ 17.34
+ $ 0.88
$ 7.19
+ $ 0.10
$ 22.20
- $ 0.66
$ 7.35
- $ 0.51
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 67.7 | 67.7 | 57.9 | 36.3 | 52.1 | 33.1 | 58.0 | 43.1 | 30.4 | 26.1 | 16.5 | 6.0 | |
| Cost of Revenues | 85.0 | 15.9 | 10.3 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | -17.3 | 51.7 | 47.6 | 27.3 | 52.1 | 33.1 | 58.0 | 43.1 | 30.4 | 26.1 | 16.5 | 6.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 23.0 | 13.8 | 14.2 | 16.6 | 12.9 | 9.1 | 7.0 | 28.9 | -1.9 | 12.0 | |
| Cost of Revenues | 6.0 | 78.9 | 0.0 | 0.0 | 0.0 | 0.0 | 2.6 | 2.5 | 2.5 | 2.3 | |
| Gross Profit | 17.0 | -65.2 | 14.2 | 16.6 | 12.9 | 9.1 | 4.4 | 26.4 | -4.4 | 9.7 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 435.1 | 420.0 | 229.8 | 150.4 | 108.4 | 89.1 | 67.6 | 31.8 | 11.2 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 116.5 | 90.3 | 71.1 | 44.2 | 41.1 | 32.2 | 28.0 | 16.8 | 8.3 | |
| Depreciation & Amortization | 10.3 | 15.9 | 10.3 | 9.0 | 13.5 | 6.9 | 6.3 | 5.6 | 4.5 | 3.0 | 1.1 | 0.3 | |
| Total Operating Expenses | 423.7 | 492.7 | 581.9 | 551.6 | 510.3 | 300.9 | 194.6 | 149.5 | 121.3 | 95.7 | 48.6 | 19.5 | |
| Operating Income | -441.0 | -441.0 | -534.3 | -515.3 | -458.2 | -267.9 | -136.6 | -106.4 | -90.9 | -69.6 | -32.2 | -13.4 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 109.0 | 113.7 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 29.0 | 29.4 | ||
| Depreciation & Amortization | 0.4 | 4.9 | 2.5 | 2.5 | 2.6 | 2.6 | 2.6 | 2.5 | 2.5 | 2.3 | ||
| Total Operating Expenses | 115.7 | 46.3 | 124.2 | 137.4 | 149.3 | 153.9 | 143.4 | 140.4 | 138.0 | 143.1 | ||
| Operating Income | -98.7 | -111.5 | -110.0 | -120.8 | -136.4 | -144.8 | -139.0 | -114.0 | -139.9 | -131.1 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 29.2 | 29.2 | 47.8 | 49.8 | 8.5 | 1.3 | 2.4 | 6.8 | 5.5 | 2.0 | 0.5 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 8.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | 28.3 | 28.3 | 15.2 | 34.1 | -16.0 | 0.0 | 2.4 | 6.8 | 5.5 | 2.0 | 0.5 | 0.0 | |
| IBT | -412.7 | -412.7 | -519.0 | -481.2 | -474.2 | -267.9 | -134.2 | -99.5 | -85.3 | -67.5 | -31.6 | -13.4 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 16.0 | -8.2 | -8.7 | -6.8 | 5.5 | -3.0 | -1.1 | -1.0 | |
| Net Income | -412.7 | -412.7 | -519.0 | -481.2 | -490.2 | -259.7 | -125.6 | -92.7 | -85.3 | -67.5 | -31.6 | -12.4 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 6.5 | 6.7 | 7.4 | 8.6 | 10.6 | 12.1 | 12.4 | 12.6 | 12.5 | 12.7 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.8 | 0.0 | ||
| Other Expense | 2.9 | 10.2 | 8.7 | 6.5 | 7.5 | 9.1 | -7.9 | 6.6 | 7.7 | 8.9 | ||
| IBT | -95.8 | -101.3 | -101.3 | -114.3 | -128.9 | -135.7 | -147.0 | -107.4 | -132.2 | -122.2 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 40.6 | -15.0 | ||
| Net Income | -95.8 | -101.3 | -101.3 | -114.3 | -128.9 | -135.7 | -147.0 | -107.4 | -132.2 | -122.2 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-5.42 | $-6.37 | $-3.66 | $-2.24 | $-1.96 | $-1.98 | $-1.88 | $-1.42 | $-0.70 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-5.42 | $-6.37 | $-3.66 | $-2.24 | $-1.96 | $-1.98 | $-1.88 | $-1.42 | $-0.70 | |
| Shares Outstanding | 108.4 | 108.4 | 98.8 | 88.8 | 77.0 | 70.9 | 56.0 | 47.2 | 43.1 | 36.0 | 22.2 | 17.7 | |
| Diluted Shares Outstanding | 108.4 | 108.4 | 98.8 | 88.8 | 77.0 | 70.9 | 56.0 | 47.2 | 43.1 | 36.0 | 22.2 | 17.7 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.46 | $-1.38 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.46 | $-1.38 | ||
| Shares Outstanding | 108.4 | 110.2 | 103.7 | 103.5 | 101.9 | 101.0 | 97.0 | 95.5 | 90.5 | 88.6 | ||
| Diluted Shares Outstanding | 108.4 | 110.2 | 103.7 | 103.5 | 101.9 | 101.0 | 97.0 | 95.5 | 90.5 | 88.6 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 130.8 | 189.2 | 226.7 | 523.5 | 123.4 | 160.0 | 57.2 | 58.9 | 340.7 | 273.1 | 75.8 | 9.8 | |
| Short Term Investments | 560.2 | 412.3 | 685.5 | 669.1 | 625.3 | 437.4 | 222.5 | 255.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 691.1 | 601.5 | 912.2 | 1,262.0 | 1,086.0 | 597.4 | 279.7 | 314.1 | 340.7 | 273.1 | 75.8 | 9.8 | |
| Accounts Receivable | 12.3 | 8.5 | 36.5 | 3.8 | 2.0 | 2.1 | 4.6 | 7.5 | 10.5 | 6.5 | 1.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | -69.3 | -337.4 | -19.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 53.8 | 29.8 | 49.7 | 20.4 | 18.6 | 17.0 | 5.1 | 3.4 | 3.7 | 1.8 | 0.8 | 0.3 | |
| Total Current Assets | 757.2 | 639.9 | 998.3 | 1,216.8 | 769.3 | 597.4 | 289.5 | 325.0 | 354.8 | 281.3 | 77.6 | 10.1 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 193.4 | 156.2 | 126.9 | 189.2 | 120.5 | 130.8 | 172.0 | 226.7 | 168.0 | 171.8 | |
| Short Term Investments | 317.7 | 303.5 | 376.9 | 412.3 | 537.6 | 560.2 | 619.3 | 685.5 | 686.8 | 736.3 | |
| Total Cash & ST Investments | 511.0 | 459.7 | 503.7 | 601.5 | 658.1 | 691.1 | 791.3 | 912.2 | 992.5 | 1,072.1 | |
| Accounts Receivable | 11.1 | 11.4 | 10.5 | 8.5 | 8.9 | 12.3 | 36.4 | 36.5 | 6.5 | 5.1 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -137.8 | -164.0 | |
| Other Current Assets | 59.8 | 24.9 | 37.1 | 29.8 | 43.9 | 53.8 | 56.3 | 49.7 | 32.2 | 26.5 | |
| Total Current Assets | 581.9 | 495.9 | 551.4 | 639.9 | 710.9 | 757.2 | 884.0 | 998.3 | 893.5 | 939.6 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 135.7 | 246.7 | 148.1 | 161.0 | 100.1 | 55.1 | 37.1 | 17.1 | 15.3 | 10.6 | 2.7 | 0.3 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 262.4 | 44.3 | 154.5 | 142.3 | 425.1 | 0.0 | 4.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 36.2 | 260.2 | 0.0 | 0.0 | 0.0 | 23.9 | 2.9 | 5.3 | 6.1 | 7.0 | 1.8 | 0.3 | |
| Total Long-Term Assets | 434.3 | 551.2 | 302.6 | 303.3 | 525.2 | 79.0 | 44.8 | 22.3 | 21.4 | 17.7 | 4.5 | 0.6 | |
| Total Assets | 1,191.5 | 1,191.0 | 1,301.0 | 1,520.1 | 1,294.5 | 676.3 | 334.3 | 347.3 | 376.2 | 299.0 | 82.1 | 10.7 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 138.3 | 188.7 | 189.9 | 246.7 | 129.1 | 135.7 | 142.5 | 148.1 | 152.6 | 156.7 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 188.3 | 196.9 | 228.1 | 304.5 | 316.5 | 262.4 | 233.0 | 154.5 | 197.3 | 41.0 | |
| Other Long-Term Assets | 16.7 | 17.3 | 16.8 | 0.0 | 16.8 | 36.2 | 0.0 | 0.0 | 0.0 | 185.9 | |
| Total Long-Term Assets | 343.3 | 402.9 | 434.8 | 551.2 | 462.4 | 434.3 | 375.5 | 302.6 | 349.9 | 383.6 | |
| Total Assets | 925.3 | 898.9 | 986.2 | 1,191.0 | 1,173.4 | 1,191.5 | 1,259.6 | 1,301.0 | 1,243.3 | 1,323.2 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 18.8 | 14.6 | 7.5 | 5.2 | 9.7 | 10.5 | 3.9 | 2.7 | 2.2 | 4.7 | 1.4 | 0.2 | |
| Short-Term Debt | 19.0 | 20.2 | 37.2 | 16.7 | 9.1 | 5.7 | 5.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 45.1 | 55.4 | 48.4 | 60.9 | 43.3 | 25.6 | 13.3 | 10.7 | 8.0 | 5.9 | 2.8 | 2.2 | |
| Current Liabilities | 105.1 | 110.9 | 115.2 | 126.6 | 125.8 | 64.3 | 35.6 | 40.6 | 31.4 | 30.7 | 10.7 | 2.4 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 13.3 | 9.8 | 12.4 | 14.6 | 13.1 | 18.8 | 13.7 | 7.5 | 3.6 | 11.6 | |
| Short-Term Debt | 27.4 | 27.0 | 38.8 | 20.2 | 19.2 | 19.0 | 18.8 | 37.2 | 34.1 | 33.5 | |
| Other Current Liabilities | 53.1 | 41.6 | 40.8 | 55.4 | 51.2 | 45.1 | 43.3 | 48.4 | 40.9 | 32.8 | |
| Current Liabilities | 93.7 | 95.5 | 112.6 | 110.9 | 105.7 | 105.1 | 97.9 | 115.2 | 92.0 | 99.9 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 87.3 | 190.0 | 96.7 | 114.0 | 64.9 | 33.6 | 12.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 87.3 | 210.2 | 115.3 | 130.7 | 74.0 | 39.3 | 18.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 220.5 | 319.1 | 250.8 | 284.5 | 254.2 | 149.3 | 64.4 | 69.4 | 75.6 | 89.1 | 14.8 | 3.1 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 70.6 | 75.6 | 80.5 | 190.0 | 82.4 | 87.3 | 92.1 | 96.7 | 101.3 | 105.6 | |
| Capital Leases | 98.0 | 102.6 | 119.3 | 210.2 | 101.6 | 87.3 | 110.9 | 115.3 | 118.3 | 122.3 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -38.9 | -12.7 | -12.9 | |
| Total Liabilities | 176.9 | 183.6 | 206.2 | 319.1 | 210.7 | 220.5 | 223.5 | 250.8 | 205.9 | 218.4 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | |
| Retained Earnings | -1,912.8 | -2,177.4 | -1,658.4 | -1,177.2 | -703.0 | -435.1 | -300.9 | -201.0 | -121.1 | -53.6 | -21.9 | -9.5 | |
| Comprehensive Income | -1.2 | 0.6 | -2.3 | -7.5 | -2.6 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | -16.4 | |
| Total Common Equity | 971.1 | 872.0 | 1,050.2 | 1,235.6 | 1,040.2 | 527.1 | 269.9 | 277.9 | 300.6 | 209.8 | 67.4 | 7.6 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -2,494.3 | -2,393.0 | -2,291.7 | -2,177.4 | -2,048.5 | -1,912.8 | -1,765.8 | -1,658.4 | -1,526.2 | -1,404.0 | |
| Comprehensive Income | 1.0 | 0.7 | 1.1 | 0.6 | 3.3 | -1.2 | -0.9 | -2.3 | -3.6 | -3.9 | |
| Total Common Equity | 748.4 | 715.3 | 779.9 | 872.0 | 962.6 | 971.1 | 1,036.1 | 1,050.2 | 1,037.4 | 1,104.9 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 106.3 | 210.2 | 115.3 | 130.7 | 74.0 | 39.3 | 18.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 971.1 | 872.0 | 1,050.2 | 1,235.6 | 1,040.2 | 527.1 | 269.9 | 277.9 | 300.6 | 209.8 | 67.4 | 7.6 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 748.4 | 715.3 | 779.9 | 872.0 | 962.6 | 971.1 | 1,036.1 | 1,050.2 | 1,037.4 | 1,104.9 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -508.8 | -519.0 | -519.0 | -481.2 | -474.2 | -267.9 | -134.2 | -99.5 | -85.3 | -67.5 | -31.6 | -12.4 | |
| Depreciation & Amortization | 9.9 | 10.3 | 10.3 | 9.0 | 7.6 | 6.9 | 6.3 | 5.6 | 4.5 | 3.0 | 1.1 | 0.3 | |
| Stock-Based Compensation | 145.4 | 154.3 | 154.3 | 134.1 | 91.4 | 47.0 | 19.9 | 15.1 | 17.0 | 15.3 | 6.7 | 1.3 | |
| Change Working Capital | -10.7 | -73.8 | 11.9 | -52.5 | -53.9 | -22.9 | 57.5 | -20.7 | 3.2 | -16.2 | 59.9 | 10.0 | |
| Change In Accounts Receivable | -7.3 | -1.0 | 27.9 | -32.7 | -1.7 | 0.1 | 2.5 | 2.9 | 2.9 | -4.0 | -5.5 | 0.0 | |
| Change In Accounts Payable | 7.2 | 6.0 | 6.8 | 2.5 | -4.6 | 0.5 | 5.1 | 1.9 | 0.2 | -0.5 | 1.8 | 0.3 | |
| Change In Inventories | -4.4 | 0.0 | 0.0 | -19.5 | 0.0 | 7.8 | 4.9 | 1.7 | 4.0 | 1.3 | -4.4 | 0.0 | |
| Other Non-cash Items | 38.0 | 79.3 | -6.3 | -3.5 | 95.8 | 2.9 | 0.6 | -3.7 | -0.6 | 0.2 | 6.7 | 0.0 | |
| Cash from Operations | -373.3 | 0.0 | 0.0 | -394.1 | -333.3 | -225.0 | -49.9 | -103.2 | -61.3 | -65.3 | 36.1 | -1.8 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -202.1 | -101.3 | -101.3 | -114.3 | -128.9 | -135.7 | -147.0 | -107.4 | -132.2 | -122.2 | |
| Depreciation & Amortization | 0.4 | 4.9 | 2.5 | 2.5 | 2.6 | 2.6 | 2.6 | 2.5 | 2.5 | 2.3 | |
| Stock-Based Compensation | 90.8 | 19.6 | 22.0 | 21.8 | 39.6 | 39.6 | 40.9 | 34.2 | 35.0 | 35.4 | |
| Change Working Capital | 0.5 | 4.4 | -19.9 | -58.8 | 2.0 | 9.9 | 29.6 | -29.7 | 3.1 | -13.7 | |
| Change In Accounts Receivable | 1.6 | 0.3 | -0.8 | -2.0 | 0.3 | 3.5 | 24.1 | 0.0 | -30.0 | -1.4 | |
| Change In Accounts Payable | 7.0 | 3.5 | -2.6 | -1.9 | 1.4 | -5.6 | 5.3 | 5.6 | 3.9 | -7.7 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -8.6 | 4.2 | |
| Other Non-cash Items | 41.2 | -4.5 | -3.0 | -0.2 | -0.5 | -1.3 | 15.7 | -20.2 | -8.7 | 1.0 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -93.1 | -101.4 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -9.4 | -5.8 | -5.8 | -14.0 | -58.4 | -12.8 | -3.6 | -6.8 | -6.4 | -10.1 | -6.2 | -2.6 | |
| Acquisitions | -131.3 | 0.0 | 0.0 | 0.0 | 0.0 | -3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -839.5 | -935.6 | -935.6 | -904.5 | -429.0 | -1,020.6 | -473.7 | -297.0 | -254.6 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 956.0 | 1,046.0 | 1,066.9 | 887.1 | 647.6 | 485.6 | 262.8 | 329.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 139.7 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 107.2 | 0.0 | 0.0 | -31.3 | 160.3 | -550.8 | -214.5 | 25.2 | -260.8 | -10.1 | -6.2 | -2.6 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -4.8 | 0.0 | -0.2 | -0.7 | -1.0 | -1.3 | -1.0 | -2.5 | -1.5 | -4.3 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -47.5 | -83.8 | |
| Investments | -680.1 | -116.7 | -55.6 | -83.2 | -169.1 | -206.1 | -300.8 | -259.6 | -149.8 | -129.4 | |
| Sales of Investment | 589.0 | 115.9 | 162.7 | 178.3 | 321.6 | 178.7 | 277.6 | 268.0 | 197.2 | 213.2 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 47.5 | 83.8 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 45.9 | 79.5 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | -16.0 | 210.2 | 94.9 | -15.4 | 56.7 | 34.7 | 20.9 | 18.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 219.6 | 0.0 | 0.0 | 119.8 | 565.8 | 693.6 | 358.6 | 72.3 | 29.0 | 141.0 | 170.5 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -2.7 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 67.2 | 0.0 | 0.0 | 10.5 | 17.2 | 43.1 | 13.1 | 4.2 | 11.2 | 2.0 | -3.1 | 73.0 | |
| Cash from Financing | 226.8 | 0.0 | 0.0 | 130.3 | 583.0 | 736.7 | 371.8 | 76.4 | 40.2 | 143.0 | 167.3 | 70.3 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 98.0 | -4.6 | -16.7 | -90.9 | 108.6 | -4.7 | -4.6 | -4.5 | -3.0 | -4.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 103.6 | 14.7 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.9 | 4.4 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 106.5 | 19.1 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -39.3 | -37.6 | -37.6 | -295.1 | 410.0 | -39.1 | 107.4 | -1.6 | -281.8 | 67.6 | 197.2 | 66.0 | |
| Closing Cash Balance | 130.8 | 202.8 | 202.8 | 240.4 | 535.5 | 125.5 | 164.6 | 57.2 | 58.9 | 340.7 | 273.1 | 75.8 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -37.9 | 37.2 | 21.9 | -54.6 | 68.7 | -10.4 | -41.1 | -54.8 | 59.4 | -2.8 | |
| Closing Cash Balance | 155.5 | 207.3 | 170.1 | 148.2 | 202.8 | 134.1 | 130.8 | 172.0 | 240.4 | 181.0 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -382.7 | -354.7 | -354.7 | -408.1 | -391.7 | -237.8 | -53.5 | -110.0 | -67.6 | -75.4 | 29.9 | -4.3 | |
| Real Free Cash Flow | -528.1 | -508.9 | -508.9 | -542.1 | -483.1 | -284.8 | -73.4 | -125.1 | -84.7 | -90.7 | 23.2 | -5.6 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -69.4 | -76.9 | -99.9 | -149.7 | -86.2 | -86.1 | -59.2 | -123.2 | -94.6 | -105.7 | |
| Real Free Cash Flow | -160.2 | -96.5 | -121.9 | -171.5 | -125.8 | -125.7 | -100.1 | -157.3 | -129.6 | -141.1 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -2.9 | -13.6 | -1.4 |
| P/S | 22.3 | 60.3 | 9.4 |
| P/B | 1.7 | 3.5 | 5.2 |
| P/FCF | -2.5 | -10.8 | -1.5 |
| Market cap | $1.1 | $1.8 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 10.6 % | 4.9 % | 0 % |
| Debt to Income | -23.7 % | -15.4 % | 0 % |
| Debt to Free cash flow | -17.8 % | -266.7 % | 0 % |
| Interest expense percentage | 0 % | -0.2 % | 44.7 % |
| Current ratio | 6.2 | 8 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -55.1 % | -30.4 % | 0 % |
| ROA | -44.6 % | -25.9 % | 0 % |
| CapEx to Revenue | 3.4 % | 35.8 % | 0 % |
| RaD to Revenue | 0 % | 454.4 % | 0 % |
| ROEM | 167,918.1 | 91495.1 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | -37.2 % | 94.3 % | 68.7 % |
| Operating margin | -832.2 % | -523.5 % | 35.5 % |
| Net margin | -774.9 % | -506.6 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 110.2 mil | 59.0 mil |
| Employee count | 0.4 tis | 0.3 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
